Pre-market: BAYN.DE Bayer AG (XETRA) at €46.28 on 11 Feb 2026: watch short-term momentum

BAYN.DE stock is trading at €46.28 in pre-market on XETRA on 11 Feb 2026, with 3,548,190 shares reported and a day range of €45.29–€46.51. The early session shows above-average liquidity and a recent one-month gain of 18.45%, marking Bayer AG as one of Germany’s most active tickers. Investors are watching upcoming catalysts including the earnings announcement on 2026-02-25 and ongoing Crop Science and Pharmaceuticals updates. This pre-market note frames the short-term trading setup, valuation context, and Meyka AI model forecasts for BAYN.DE stock.

Why BAYN.DE stock is most active in pre-market

BAYN.DE stock is drawing volume because the price sits near its 52-week high €46.74 and traders are repositioning ahead of Bayer’s 2026-02-25 earnings announcement. Pre-market activity shows relVolume 0.59 versus the average, indicating institutional interest. One claim: sharp gains over the past three months (up 74.23%) are attracting momentum traders to XETRA ahead of corporate updates.

BAYN.DE stock fundamentals and valuation

Bayer AG (BAYN.DE) posts a market capitalization of €45.36B, price-to-book 1.53, and price-to-sales 0.99, signalling value relative to peers in the Healthcare sector. Earnings per share is -0.20 and trailing PE is -230.85 because of negative net income, but free cash flow yield is 8.68%, supporting operational strength. One claim: balance sheet leverage remains significant with debt-to-equity 1.34, so credit metrics will matter to long-term investors.

BAYN.DE stock technicals and trading signals

Technicals show short-term strength: RSI 73.81 (overbought), ADX 46.38 (strong trend), and MACD histogram 0.02, suggesting momentum remains but may be stretched. Price sits above the 50-day average €39.45 and 200-day average €30.18, highlighting the recent rally. One claim: traders should watch a break above €46.73 for additional upside or failure near the day high €46.51 for a pullback play.

Meyka Grade & Forecast for BAYN.DE stock

Meyka AI rates BAYN.DE with a score out of 100: 68.08 (Grade B) and suggests HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly €47.50 (+2.64% vs €46.28), quarterly €51.73 (+11.78%), and yearly €12.86 (-72.23%). Forecasts are model-based projections and not guarantees.

BAYN.DE stock risks and near-term catalysts

Key risks include legal and regulatory outcomes, Crop Science margin pressure, and elevated net debt with netDebt/EBITDA 5.53, which could amplify downside. Catalysts include the 2026-02-25 earnings release, trial updates, and seasonal Crop Science demand; each can swing sentiment quickly. One claim: with dividend per share €0.11, income is negligible relative to volatility, so traders focus on earnings and legal timelines.

BAYN.DE stock trading strategies and sector context

In Germany’s Healthcare sector, BAYN.DE stock trades cheaper on PB than many peers while facing industry headwinds; sector YTD is modestly positive, supporting selective long exposure. Short-term traders may prefer momentum entries above €47.00 with stops near €45.00; longer-term investors should monitor debt reduction and earnings recovery. One claim: position sizing is crucial given volatility and mixed profitability metrics.

Final Thoughts

BAYN.DE stock is active pre-market on 11 Feb 2026 at €46.28, backed by strong volume and recent momentum. Our view: short-term momentum favors continuation toward the Meyka quarterly model target €51.73 (implied +11.78%), but the wide split between quarterly and yearly forecasts signals model uncertainty. Valuation metrics such as PB 1.53 and price-to-sales 0.99 show relative value, while negative EPS and netDebt/EBITDA 5.53 highlight financial risk. Traders should treat the upcoming 2026-02-25 earnings release as the primary catalyst and manage risk with tight stops or conservative size. Meyka AI assigns a Grade B (68.08) and suggests HOLD; our practical price targets: conservative €43.00, base €50.00, bull €60.00. Remember forecasts are model-based projections and not guarantees. For live order-book moves see the Investing.com historical data report and short-interest updates on MarketBeat. For more tools and the live Bayer page visit our internal Meyka stock page: https://meyka.ai/stocks/BAYN.DE.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.